✦ LIBER ✦

Endovascular repair of a giant carotid pseudoaneurysm with the use of Viabahn stent graft

✍ Scribed by Kamal Gupta; Kathy Dougherty; Heinz Hermman; Zvonimir Krajcer

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 330 KB
Volume: 62
Category: Article
ISSN: 1522-1946
DOI: 10.1002/ccd.20006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

First-in-man use of a tapered endovascul

First-in-man use of a tapered endovascular stent graft for treatment of aneurysm after coarctation repair

✍ Fabian Nietlispach; Jonathon Leipsic; Namal Wijesinghe; John G. Webb; Ronald G. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 377 KB 👁 1 views

## Abstract **Objectives**: Endovascular stenting of aneurysms late after surgical repair of coarctation may have to deal with marked changes in aortic diameter proximal and distal to the aneurysm. We report our first‐in‐man successful use of a custom‐made tapered (variable diameter) covered stent.

Endovascular repair of traumatic pseudoa

Endovascular repair of traumatic pseudoaneurysm by uncovered self-expandable stenting with or without transstent coiling of the aneurysm cavity

✍ Abid R. Assali; Stefano Sdringola; Ali Moustapha; Michael Rihner; Ali E. Denktas 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 2 views

Lengthening of proximal implantation sit

Lengthening of proximal implantation site during endovascular repair of thoracic aortic aneurysm: Preservation of carotid patency with retrograde trans endograft deployment of a carotid stent

✍ Guering Eid-Lidt; Samuel Ramirez; Jorge Gaspar 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB 👁 1 views

Lack of clinical long-term benefit with

Lack of clinical long-term benefit with the use of a drug eluting stent compared to use of a bare metal stent in saphenous vein grafts

✍ Giuseppe Gioia; Alberto Benassi; Raghar Mohendra; Khaza Chowdhury; Iqbal Masood; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 179 KB 👁 3 views

## Abstract Background: Small randomized trials have shown short‐term improved outcome with drug‐eluting stents (DES) over bare metal stent (BMS) in saphenous vein graft (SVG) interventions by reducing in‐stent restenosis and target vessel revascularization (TVR). It is not clear, however, if these